<--- Back to Details
First PageDocument Content
Complement deficiency / Immunology / Type 1 hypersensitivity / Urticaria / Angioedema / Allergy / Food allergy / American Academy of Allergy /  Asthma /  and Immunology / Acquired C1 esterase inhibitor deficiency / Health / Medicine / Immune system
Date: 2011-02-28 00:56:52
Complement deficiency
Immunology
Type 1 hypersensitivity
Urticaria
Angioedema
Allergy
Food allergy
American Academy of Allergy
Asthma
and Immunology
Acquired C1 esterase inhibitor deficiency
Health
Medicine
Immune system

Table 14 Urticaria and angioedema

Add to Reading List

Source URL: www.aaaai.org

Download Document from Source Website

File Size: 145,79 KB

Share Document on Facebook

Similar Documents

Medicine / Health / Complement deficiency / Clinical medicine / Angioedema / Adverse effect / Hereditary angioedema

[Product Monograph Template - Schedule D]

DocID: 1qWQL - View Document

Blood / Coagulation system / Anatomy / CSL Behring / Von Willebrand disease / Factor VIII / Coagulation / CSL Limited / Hereditary angioedema / Haemophilia / Factor IX / Factor VII

News Releases Global Home | CSL Behring US | CSL Plasma | All CSL Behring Web Sites  

DocID: 1qHpD - View Document

Neurochemistry / Medicine / Clinical medicine / Complement deficiency / RTT / Sodium channel blockers / Euphoriants / Calcium channel blockers / Hereditary angioedema / Syringe / Angioedema / Ketamine

Microsoft Word - CINRYZE.Product Monographdoc

DocID: 1qE2h - View Document

Medicine / Health / Clinical medicine / Clinical pharmacology / GABAA receptor positive allosteric modulators / Complement deficiency / Hereditary angioedema / Serpinopathies / Icatibant / Adverse effect / Clinical trial / Zolpidem

Microsoft Word - FIRAZYR.Product Monographdoc

DocID: 1qA9x - View Document

Medicine / CSL Behring / Clinical medicine / Microbiology / Coagulation system / CSL Limited / Hereditary angioedema / Behring / CSL / Coagulation / Marburg

Fact Sheet CSL BehringCSL Sales $5.5 Billion CSL Behring is a global biotherapeutics leader driven by our promise to save lives. Focused on serving patients’ needs by using the latest technologies, we develop

DocID: 1pVHk - View Document